Trials / Conditions / Thalassemia Intermedia

Thalassemia Intermedia

9 registered clinical trials studyying Thalassemia Intermedia — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Growth Evaluation, Health Promotion, and Clinical Management in Children and Adolescents With Thalassemia NCT06931912	Institute of Hematology & Blood Diseases Hospital, China	N/A
Active Not Recruiting	EDIT-301 for Autologous Hematopoietic Stem Cell Transplant (HSCT) in Participants With Transfusion-Dependent B NCT05444894	Editas Medicine, Inc.	Phase 1 / Phase 2
Terminated	Apotransferrin in Patients With β-thalassemia NCT03993613	Prothya Biosolutions	Phase 2
Unknown	"Iron Overload and Endocrinological Diseases" NCT06137079	Azienda Ospedaliero-Universitaria di Modena	—
Unknown	Therapeutic Effect and Safety of Combined Hydroxyurea With Recombinant Human Erythropoietin. NCT01624038	Ain Shams University	Phase 2 / Phase 3
Completed	Prevalence of Pulmonary Hypertension (PAH) in Patients With Thalassemia NCT01496963	Ente Ospedaliero Ospedali Galliera	—
Completed	Traditional Chinese Medicine in the Supportive Management of Anaemic and Cytopenic (Leukopenia, Thrombocytopen NCT01224496	Singapore General Hospital	Phase 1 / Phase 2
Completed	Combination Therapy of Hydroxyurea With L-Carnitine and Magnesium Chloride in Thalassemia Intermedia NCT00809042	Shiraz University of Medical Sciences	Phase 2
Completed	Efficacy and Safety of Neridronate (Nerixia®)to Treat Osteoporosis in Patients With TM and TI NCT01140321	Ente Ospedaliero Ospedali Galliera	Phase 2